Search Results - "HORSMAN, J. M"

Primary thyroid lymphoma: The 40 year experience of a UK lymphoma treatment centre by ALZOUEBI, M, GOEPEL, J. R, HORSMAN, J. M, HANCOCK, B. W

“…We report the 40-year unselected experience of a UK lymphoma treatment centre. Between 1970 and 2010, 3363 cases of non-Hodgkin lymphoma were managed by the…”
Get full text

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma by HANCOCK, B. W, WHEATLEY, K, BURROWS, L, GORE, M, HARRIS, S, IVES, N, HARRISON, G, HORSMAN, J. M, MIDDLETON, M. R, THATCHER, N, LORIGAN, P. C, MARSDEN, J. R

“…To evaluate low-dose extended duration interferon alfa-2a as adjuvant therapy in patients with thick (> or = 4 mm) primary cutaneous melanoma and/or…”
Get full text

Primary bone lymphoma : A retrospective analysis by HORSMAN, J. M, THOMAS, J, HOUGH, R, HANCOCK, B. W

“…The aim of this study was to retrospectively define those patients with unequivocal primary bone lymphoma presenting to the Sheffield Lymphoma Group and…”
Get full text

Second primary malignancies after treatment for malignant lymphoma by OKINES, A, THOMSON, C. S, RADSTONE, C. R, HORSMAN, J. M, HANCOCK, B. W

“…To determine the incidence and possible causes of second primary malignancies after treatment for Hodgkin's and Non-Hodgkin's lymphoma (HL and NHL). A cohort…”
Get full text

Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom by LESTER, J. E, DODWELL, D, HORSMAN, J. M, MORI, S, COLEMAN, R. E

“…New therapeutic options in breast cancer have improved survival but consequently increase the relevance of late complications. Ovarian suppression/ablation and…”
Get full text

Is there a relationship between treatment for infertility and gestational trophoblastic disease? by Bates, M., Everard, J., Wall, L., Horsman, J.M., Hancock, B.W.

“…BACKGROUND: The aim of the study was to record the incidence of treatment for infertility prior to development of gestational trophoblastic disease (GTD)…”
Get full text

Space allowance for gestating sows in pens: behavior and immunity by Salak-Johnson, J L, DeDecker, A E, Horsman, M J, Rodriguez-Zas, S L

“…Different floor space allowances for dry, pregnant sows in pens were evaluated to determine the impacts of space on sow behavior, immune, and cortisol…”
Get full text

Localised Extranodal Lymphoma of the Head and Neck: The Sheffield Lymphoma Group Experience (1971–2000) by Hart, S., Horsman, J.M., Radstone, C.R., Hancock, H., Goepel, J.R., Hancock, B.W.

“…Aims: Over the 30-year period from 1971–2000, 3750 cases of lymphoma were referred to the Sheffield Lymphoma Group for investigation and treatment. Of these,…”
Get full text

Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract: Sheffield Lymphoma Group experience (1989-1998) by Koh, P K, Horsman, J M, Radstone, C R, Hancock, H, Goepel, J R, Hancock, B W

“…Extranodal non-Hodgkin's lymphoma (NHL) of the gastrointestinal tract accounts for about one third of all extranodal NHL. We retrospectively reviewed the…”
Get more information

Peripheral T cell lymphoma: The Sheffield Lymphoma Group experience (1977-2001) by Musson, R, Radstone, C R, Horsman, J M, Hancock, H, Goepel, J R, Hancock, B W

“…Peripheral T-cell lymphomas (PTCL) account for approximately 10% of all non-Hodgkin's lymphomas. The aim of this retrospective study was to analyse the…”
Get more information

Health care workers and HIV/AIDS: A critical review of the literature by Horsman, Janet M., Sheeran, Paschal

“…This paper reviews the extensive literature which looks at the impact of HIV/AIDS on health care workers (HCWs). The knowledge and attitudes of HCWs toward…”
Get full text

Space allowance for gestating sows in pens: Behavior and immunity1 by Salak-Johnson, J. L., DeDecker, A. E., Horsman, M. J., Rodriguez-Zas, S. L.

“…Different floor space allowances for dry, pregnant sows in pens were evaluated to determine the impacts of space on sow behavior, immune, and cortisol…”
Get full text

Prognostic markers in malignant lymphoma: an analysis of 1,198 patients treated at a single centre by Low, S E, Horsman, J M, Hancock, H, Walters, S J, Hancock, B W

“…The prognostic significance of 20 putative markers has been assessed in a consecutive series of 1,198 patients with malignant lymphoma seen by the Sheffield…”
Get more information

Quality of life, support and smoking in advanced lung cancer patients: a qualitative study by Rowland, C, Danson, S J, Rowe, R, Merrick, H, Woll, P J, Hatton, M Q, Wadsley, J, Ellis, S, Crabtree, C, Horsman, J M, Eiser, C

“…Lung cancer is the most common cancer and smoking is the principal cause. Due to poor survival rates, symptom palliation and promotion of health-related…”
Get more information

Impact of the revised FIGO/WHO system on the management of patients with gestational trophoblastic neoplasia by El-Helw, L.M, Coleman, R.E, Everard, J.E, Tidy, J.A, Horsman, J.M, Elkhenini, H.F, Hancock, B.W

“…Abstract Objective To study the effect of a change in disease scoring systems on the management of patients with gestational trophoblastic neoplasia (GTN) in…”
Get full text

Non-Hodgkin's lymphoma presenting with spinal involvement: the Sheffield Lymphoma Group experience (1970-2000) by Ching, H Y, Horsman, J M, Radstone, C R, Hancock, H, Timperley, W R, Hancock, B W

“…Spinal non-Hodgkin's lymphoma is rare. We retrospectively reviewed the clinical and histopathologic records of 39 consecutive patients referred to the…”
Get more information

The Management and Survival of Patients with Advanced Germ-Cell Tumours: Improving Outcome in Intermediate and Poor Prognosis Patients by Bhala, N., Coleman, J.M., Radstone, C.R., Horsman, J.M., George, J., Hancock, B.W., Hatton, M.Q., Coleman, R.E.

“…Aims: The survival of germ-cell tumours (GCT) was transformed after the introduction of cisplatin-based therapy. Previous trials have indicated BEP (bleomycin,…”
Get full text

Prevention of anastrozole induced bone loss with monthly oral ibandronate: Final 5 year results from the ARIBON trial by Lester, J.E, Dodwell, D, Brown, J.E, Purohit, O.P, Gutcher, S.A, Ellis, S.P, Thorpe, R, Horsman, J.M, Coleman, R.E

“…Abstract Purpose The ARIBON trial is a double blind, randomised, placebo controlled study designed to evaluate the impact of ibandronate on bone mineral…”
Get full text

An orientation anisotropy in the effects of scaling vertical disparities by Frisby, John P, Buckley, David, Grant, Helen, Gårding, Jonas, Horsman, Janet M, Hippisley-Cox, Stephen D, Porrill, John

“…Gårding et al. (Vis Res 1995;35:703–722) proposed a two-stage theory of stereopsis. The first uses horizontal disparities for relief computations after they…”
Get full text

The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice? by LIM, S.Y, HORSMAN, J.M, HANCOCK, B.W

“…The Mantle Cell Lymphoma International Prognostic Index (MIPI) combines four factors to differentiate low-, intermediate- and high-risk prognostic groups in…”
Get full text